DIPROLENE

This brand name is authorized in United States. It is also authorized in Canada, France, Netherlands, New Zealand, Poland.

Active ingredients

The drug DIPROLENE contains one active pharmaceutical ingredient (API):

1	Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DIPROLENE AF Cream	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC01	Betamethasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00629367
FR	Base de données publique des médicaments	69337589
NL	Z-Index G-Standaard	12513040
NL	Z-Index G-Standaard, PRK	79979
NZ	Medicines and Medical Devices Safety Authority	2154, 2159
PL	Rejestru Produktów Leczniczych	100019427, 100382984, 100413450, 100426581
US	FDA, National Drug Code	0085-0517, 0085-0575, 0085-0962